Ono Pharmaceutical Co., Ltd. and Astellas Pharma Inc. today announced that RECALBON Tablets 1 mg (Ono) / Bonoteo® Tablets 1 mg (Astellas) (generic name: minodronic acid hydrate) was granted a Japanese marketing approval on January 21, 2009.
The details can be read here.
No comments:
Post a Comment